OXIG vs. IQE, NANO, DARK, SCT, SOPH, CCC, NETW, SXS, MCRO, and RSW
Should you be buying Oxford Instruments stock or one of its competitors? The main competitors of Oxford Instruments include IQE (IQE), Nanoco Group (NANO), Darktrace (DARK), Softcat (SCT), Sophos Group plc (SOPH.L) (SOPH), Computacenter (CCC), Network International (NETW), Spectris (SXS), Micro Focus International (MCRO), and Renishaw (RSW). These companies are all part of the "computer and technology" sector.
Oxford Instruments vs.
IQE (LON:IQE) and Oxford Instruments (LON:OXIG) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, dividends, valuation, media sentiment, earnings, risk, analyst recommendations and profitability.
Oxford Instruments has a net margin of 10.78% compared to IQE's net margin of -17.89%. Oxford Instruments' return on equity of 14.14% beat IQE's return on equity.
In the previous week, IQE had 1 more articles in the media than Oxford Instruments. MarketBeat recorded 1 mentions for IQE and 0 mentions for Oxford Instruments. IQE's average media sentiment score of 0.75 beat Oxford Instruments' score of 0.00 indicating that IQE is being referred to more favorably in the media.
Oxford Instruments has higher revenue and earnings than IQE. IQE is trading at a lower price-to-earnings ratio than Oxford Instruments, indicating that it is currently the more affordable of the two stocks.
66.7% of IQE shares are owned by institutional investors. Comparatively, 72.3% of Oxford Instruments shares are owned by institutional investors. 19.3% of IQE shares are owned by insiders. Comparatively, 5.0% of Oxford Instruments shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
IQE presently has a consensus target price of GBX 20, suggesting a potential upside of 124.72%. Oxford Instruments has a consensus target price of GBX 1,978.75, suggesting a potential upside of 17.92%. Given IQE's stronger consensus rating and higher probable upside, equities research analysts plainly believe IQE is more favorable than Oxford Instruments.
IQE has a beta of 1.86, suggesting that its share price is 86% more volatile than the S&P 500. Comparatively, Oxford Instruments has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.
IQE received 50 more outperform votes than Oxford Instruments when rated by MarketBeat users. Likewise, 75.00% of users gave IQE an outperform vote while only 67.51% of users gave Oxford Instruments an outperform vote.
Summary
Oxford Instruments beats IQE on 10 of the 18 factors compared between the two stocks.
Get Oxford Instruments News Delivered to You Automatically
Sign up to receive the latest news and ratings for OXIG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxford Instruments Competitors List
Related Companies and Tools
This page (LON:OXIG) was last updated on 4/26/2025 by MarketBeat.com Staff
Buy OXIG Stock Free OXIG Stock Alerts